|
1
|
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.
|
JAMA
|
2004
|
8.12
|
|
2
|
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.
|
Thyroid
|
2014
|
2.77
|
|
3
|
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
|
Thyroid
|
2012
|
2.71
|
|
4
|
Thyroid Nodules.
|
N Engl J Med
|
2015
|
2.65
|
|
5
|
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.
|
J Nucl Med
|
2012
|
2.08
|
|
6
|
Acute bacterial suppurative thyroiditis: a clinical review and expert opinion.
|
Thyroid
|
2010
|
1.65
|
|
7
|
Anaplastic thyroid cancer.
|
Endocrinol Metab Clin North Am
|
2008
|
1.54
|
|
8
|
A 2011 survey of clinical practice patterns in the management of Graves' disease.
|
J Clin Endocrinol Metab
|
2012
|
1.43
|
|
9
|
Subclinical hyperthyroidism: controversies in management.
|
Am Fam Physician
|
2002
|
1.42
|
|
10
|
Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells.
|
J Clin Endocrinol Metab
|
2002
|
1.24
|
|
11
|
Clinical review: Ectopic cervical thyroid carcinoma--review of the literature with illustrative case series.
|
J Clin Endocrinol Metab
|
2011
|
1.21
|
|
12
|
The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules?
|
J Clin Endocrinol Metab
|
2004
|
1.20
|
|
13
|
Akt1 contains a functional leucine-rich nuclear export sequence.
|
Biochem Biophys Res Commun
|
2005
|
1.15
|
|
14
|
Hypothyroidism.
|
Endocrinol Metab Clin North Am
|
2007
|
1.14
|
|
15
|
Myxedema coma.
|
J Intensive Care Med
|
2007
|
1.12
|
|
16
|
The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism.
|
Thyroid
|
2009
|
1.07
|
|
17
|
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.
|
J Clin Endocrinol Metab
|
2013
|
1.05
|
|
18
|
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
|
Thyroid
|
2010
|
1.03
|
|
19
|
Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
|
Otolaryngol Head Neck Surg
|
2005
|
1.02
|
|
20
|
Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
|
Clin Endocrinol (Oxf)
|
2011
|
1.01
|
|
21
|
KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity.
|
J Clin Endocrinol Metab
|
2005
|
0.98
|
|
22
|
Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism.
|
J Clin Endocrinol Metab
|
2005
|
0.98
|
|
23
|
Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
|
Endocr Relat Cancer
|
2012
|
0.96
|
|
24
|
17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels.
|
J Clin Endocrinol Metab
|
2004
|
0.95
|
|
25
|
Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome.
|
Thyroid
|
2009
|
0.92
|
|
26
|
Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature.
|
Thyroid
|
2013
|
0.91
|
|
27
|
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin.
|
Thyroid
|
2012
|
0.90
|
|
28
|
Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis.
|
Thyroid
|
2005
|
0.90
|
|
29
|
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells.
|
Mol Carcinog
|
2004
|
0.90
|
|
30
|
Metastases of well-differentiated thyroid cancer to the gastrointestinal system.
|
Thyroid
|
2010
|
0.89
|
|
31
|
Age and the thyrotropin response to hypothyroxinemia.
|
J Clin Endocrinol Metab
|
2010
|
0.89
|
|
32
|
Thyroid disorders in pregnancy.
|
Endocrinol Metab Clin North Am
|
2011
|
0.87
|
|
33
|
Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.
|
Thyroid
|
2014
|
0.86
|
|
34
|
Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters.
|
Ther Drug Monit
|
2015
|
0.86
|
|
35
|
Current treatment modalities for spinal metastases secondary to thyroid carcinoma.
|
Thyroid
|
2014
|
0.85
|
|
36
|
Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
|
AJR Am J Roentgenol
|
2002
|
0.85
|
|
37
|
Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
|
J Clin Endocrinol Metab
|
2002
|
0.84
|
|
38
|
Micropapillary thyroid cancer: should we aspirate all nodules regardless of size?
|
J Clin Endocrinol Metab
|
2006
|
0.84
|
|
39
|
Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
|
Thyroid
|
2005
|
0.83
|
|
40
|
Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen.
|
J Thyroid Res
|
2011
|
0.83
|
|
41
|
The effect of medications on thyroid function tests.
|
Med Clin North Am
|
2012
|
0.83
|
|
42
|
A 2013 survey of clinical practice patterns in the management of primary hypothyroidism.
|
J Clin Endocrinol Metab
|
2014
|
0.82
|
|
43
|
Two cases of statin-induced myopathy caused by induced hypothyroidism.
|
Endocr Pract
|
2008
|
0.80
|
|
44
|
Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.
|
Endocr Pract
|
2013
|
0.80
|
|
45
|
The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress.
|
J Endocrinol
|
2012
|
0.80
|
|
46
|
Thyrotoxicosis-induced ventricular arrhythmias.
|
Thyroid
|
2008
|
0.79
|
|
47
|
Overt and 'subclinical' hypothyroidism in women.
|
Obstet Gynecol Surv
|
2006
|
0.79
|
|
48
|
Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma.
|
Thyroid
|
2009
|
0.78
|
|
49
|
Differences in SPET analysis of thyroid-associated orbitopathy.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.78
|
|
50
|
Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.
|
Thyroid
|
2013
|
0.78
|
|
51
|
Age modifies the response to recombinant human thyrotropin.
|
Thyroid
|
2010
|
0.78
|
|
52
|
Salivary gland malignancy and radioiodine therapy for thyroid cancer.
|
Thyroid
|
2010
|
0.78
|
|
53
|
Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options.
|
J Clin Endocrinol Metab
|
2012
|
0.77
|
|
54
|
Hypocortisolemia in Graves hyperthyroidism.
|
Endocr Pract
|
2009
|
0.77
|
|
55
|
Thyroid cancer molecular signaling pathways and use of targeted therapy.
|
Endocrinol Metab Clin North Am
|
2007
|
0.77
|
|
56
|
Thyroid function: Gestational hypothyroidism--a need for universal screening?
|
Nat Rev Endocrinol
|
2012
|
0.76
|
|
57
|
Transient Graves' hyperthyroidism during pregnancy in a patient with Hashimoto's hypothyroidism.
|
Thyroid
|
2005
|
0.76
|
|
58
|
Variability in reporting fine-needle aspirations of thyroid.
|
Thyroid
|
2010
|
0.75
|
|
59
|
Repositioning therapy for thyroid cancer: new insights on established medications.
|
Endocr Relat Cancer
|
2014
|
0.75
|
|
60
|
Autoimmune thyroid disease and chronic urticaria.
|
Clin Endocrinol (Oxf)
|
2007
|
0.75
|
|
61
|
The EUROPA trial.
|
Lancet
|
2003
|
0.75
|
|
62
|
Thyroid Nodules.
|
N Engl J Med
|
2016
|
0.75
|
|
63
|
A new paradigm in the treatment of carcinoma: specific molecular targeting.
|
Endocrinology
|
2004
|
0.75
|
|
64
|
Treatment of hypothyroidism: possibilities on the horizon.
|
Thyroid
|
2013
|
0.75
|
|
65
|
Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy.
|
Thyroid
|
2009
|
0.75
|
|
66
|
Thyroid nodule and thyroid cancer management pre- and post-cardiac transplantation.
|
J Heart Lung Transplant
|
2010
|
0.75
|
|
67
|
Thyroid disorders and diseases.
|
Med Clin North Am
|
2012
|
0.75
|
|
68
|
WHAT IS THE CLINICAL ROLE OF ORAL LIQUID PREPARATIONS IN THE TREATMENT OF PATIENTS WITH HYPOTHYROIDISM?
|
Endocr Pract
|
2017
|
0.75
|
|
69
|
18F- FDG-PET SUV as a Prognostic Marker of Increasing Size in Thyroid Cancer Tumors.
|
Endocr Pract
|
2016
|
0.75
|
|
70
|
Intravenous methimazole in the treatment of refractory hyperthyroidism.
|
Thyroid
|
2006
|
0.75
|